Profit before interest, taxes and amortization: Chromocell Therapeutics Corp. (CHRO)
Chromocell Therapeutics (CHRO) is developing an R&D platform to create small molecules for chronic pain. The EBITDA distribution by period on the GURU.Markets chart demonstrates profit dynamics, where is the current value of the indicator. The company relies on strict pharmaceutical supply logistics and is capturing an open niche for non-opioid drugs, building its client base during clinical trials.
Chromocell Therapeutics Corp. (CHRO) - metric breakdowns and financial figures
- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- book capitalization data:
- debt level and financial liquidity data:
Total Debt to Equity Ratio Chromocell Therapeutics|CHRO - Long-Term Debt to Capital|Current Liabilities to Capital Chromocell Therapeutics Corp|CHRO - Company Debts|Debt to Book Capitalization Ratio Chromocell Therapeutics|CHRO - Company Long-Term Debt|Company Short-Term Debt Chromocell Therapeutics|Intermediate Coverage Ratio chromocell.com
- earnings and multiples data:
CHRO - Net Income|Future Net Profit Chromocell Therapeutics|CHRO - P/E Multiple|Future Price to Earnings Multiple chromocell.com|CHRO - PEG Multiple|Company Value to EBITDA Chromocell Therapeutics|CHRO - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year Chromocell Therapeutics|CHRO - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth chromocell.com|CHRO - Earnings per share growth in current year|Net earnings per share change forecast for next year Chromocell Therapeutics
Analysis of all company metrics:Chromocell (CHRO)
Absolute operating profit measures the actual cash flow from core operations before depreciation and taxes, allowing investors to filter out market noise and assess the issuer's fundamental solvency. For Chromocell Therapeutics (CHRO), the EBITDA_Co metric verifies the funding efficiency of joint research with institutes, confirming whether non-opioid developments are capable of generating sustainable capital for long-term business growth.
Competitors of Chromocell Therapeutics (CHRO)
Income before deduction of interest, taxes and amortization BIIB|NBIX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization regencellbioscience.com|Axsome Therapeutics, Inc. (AXSM) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization ACADIA Pharma|Profit before payment of interest, taxes and amortization Xenon Pharmaceuticals Inc|Profit before interest, taxes and amortization Viking Therapeutics Corp VKTX|Operating profit EBITDA SUPN|Operating profit before deduction of amortization catalystpharma.com CPRX|Operating profit EBITDA DNLI (Denali Therapeutics Inc.)|Harmony Biosciences Inc (HRMY) - Profit before interest, taxes and amortization|BHVN - Profit before payment of interest, taxes and amortization|AMLX: Profit before payment of interest, taxes and amortization|Trevi Therapeutics (TRVI) - Profit before payment of interest, taxes and amortization|PRAX (praxismedicines.com) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization AVXL|CBLL: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization PRTA (Prothena Corp)|Company profit before taxes, interest and amortization ALEC|Operating profit EBITDA ANNX (Annexon, Inc.)|Income before deduction of interest, taxes and amortization OMER|Neurogene - Operating profit EBITDA|Profit before interest, taxes and amortization AC Immune S.A.|Voyager Pharma (VYGR) - Profit before payment of interest, taxes and amortization|Neumora Corp - Income before deduction of interest, taxes and amortization|SCLX (Scilex Holding Company) - Operating profit EBITDA|Operating profit EBITDA tevogen.com|Profit before payment of interest, taxes and amortization Alpha Cognition (ACOG)|CGTX: Profit before deduction of interest, taxes, depreciation and amortization|Operating profit EBITDA IKT (Inhibikase)|Cassava Pharma (SAVA) - Profit before interest, taxes and amortization|ASRT: Operating profit before deduction of amortization|COYA - Operating profit EBITDA|VTGN (vistagen.com) - Operating profit before deduction of amortization|OVID: Company profit before taxes, interest and amortization|ABOS (Acumen Pharma) - Operating profit EBITDA|CervoMed Corporation (CRVO) - Operating income before deduction of amortization|Operating profit EBITDA ATHE|Operating profit before deduction of amortization clene.com CLNN|Profit before payment of interest, taxes and amortization PepGen PEPG|Operating income before deduction of amortization Jupiter Neurosciences, Inc. (JUNS)|Relmada - Operating profit EBITDA|Annovis Bio Corporation (ANVS) - Operating profit before deduction of amortization|GRCE: Operating profit EBITDA|fireflyneuro.com - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization ANEW Medical|NRSN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Reviva Pharmaceuticals Holdings (RVPH)|MTVA - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization NeurAxis, Inc. NRXS|HSDT: Operating profit before amortization|Passage Bio Corp - Operating profit EBITDA|Profit before interest, taxes and amortization Neuphoria Therapeutics Inc.|NERV (Minerva Neurosciences Corp) - Operating profit before deduction of amortization|Athira Pharma Corp (ATHA) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Addex Therapeutics|ALZN: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Cyclerion Therapeutics (CYCN)|PTIX - Profit before interest, taxes and amortization|Operating profit EBITDA KTTA (Pasithea Therapeutics Corp.)|CRGT - Operating profit before deduction of amortization|Avenue Therapeutics - Operating profit EBITDA|Income before deduction of interest, taxes and amortization BCLI (brainstorm-cell.com)|Cara Therapeutics (CARA) - Profit before payment of interest, taxes and amortization|Eliem Therapeutics Inc. - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Intra-Cellular Therapies Inc.|Profit before interest, taxes and amortization Longboard LBPH|Profit before payment of interest, taxes and amortization Marinus Pharmaceuticals (MRNS)|Operating profit before deduction of amortization nkgenbiotech.com NKGN|Profit before payment of interest, taxes and amortization NeuroBo Pharmaceuticals, Inc. NRBO|Sage Therapeutics Inc. (SAGE) - Profit before interest, taxes and amortization|Neurotrope - Operating profit EBITDA|Trevena Inc (TRVN) - Operating profit before deduction of amortization|VIGL: Operating profit EBITDA|Profit before interest, taxes and amortization anewmeds.com (WENA)|Profit before payment of interest, taxes and amortization Cerevel Therapeutics, Inc.
